Flexible RNA therapy facilities for a rapidly advancing sector.
Are you at the forefront of RNA technology?
These therapies are developing more quickly than many companies—established and new—can react. But you don’t just want to react to this revolutionary technology; you want to lead it. That means you need engineering, design, and construction expertise in your corner to help you right-size your process, navigate a complex regulatory environment, and create a flexible facility that can adapt with the industry and your organization.
How can CRB help you?
Given the broad range of therapies and processes under the RNA umbrella, this market is unlike any other biopharma sector. In fact, many of the technologies skirt the line between biotech and pharma. How do you determine the right type of process or facility for your ideal outcome? You work with a firm that has deep experience on both sides of that coin. CRB’s teams have successfully completed an unparalleled number of ATMP and oligonucleotide projects. We combine that practical experience with creativity and interdisciplinary collaboration to provide innovative solutions tailored to your unique needs.
Whether you’re in the start-up phase looking for guidance to build your first facility, or you’re an established company extending the scope of your portfolio, we can help you achieve your aims.
Tell us more about your project.
Download Now – Horizons: Life Sciences
Our 2022 edition of the life sciences report, built on the insights of nearly 500 industry leaders, explores the transformative change this field is poised to undergo in the wake of the pandemic and ever-increasing investment in R&D.